ANI Pharmaceuticals Inc (ANIP) income statement
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3046% below fair value
$71.47+1.48 (+2.11%)
Close on Nov 18, 2026Market cap $1.64BP/E 15.2Yield –
ANI Pharmaceuticals Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 60.4%
- Operating margin
- 15.4%
- Net margin
- 11.1%
- Return on equity, FY2025
- 16.6%
Financial strength
- Current ratio
- 2.91
- Debt to equity
- 0.50
- Debt to assets
- 20.2%
- Cash to current liabilities
- 127.0%
Valuation
- P/E ratio
- 15.2
- Price to sales
- 1.68
- Price to book
- 2.75
- Dividend yield
- –
See a number that looks wrong?